H.866

An act relating to prescription drug manufacturer cost transparency

Sponsors:

Location: House Committee on Health Care

Last Recorded Action: 5/2/2016 - Referred to the Committee on Health Care

Committee Activity - Meeting Full List

2015 - 2016 Legislative Session

Thursday, January 21, 2016

Committee(s):

House Committee on Health Care

9:00 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

9:00-10:30 AM. Overview of Issues.

Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Brian Murphy, Pharmacy Program Director, Blue Cross/Blue Shield of Vermont
Michael Fischer MD MS, Associate Professor of Medicine, Harvard Medical School, Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham & Women's
Ameet Sarpatwari JD PhD, Instructor, Harvard Medical School, Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham & Women's
Aaron French, Deputy Commissioner,  Health Services and Managed Care, Department of Vermont Health Access
Michael Ouellette, Clinical Pharmacy Manager, Goold Health Systems

Friday, January 22, 2016

Committee(s):

House Committee on Health Care

10:30 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

Joint with several committees, Room 11.
Representative Peter Welch and staff

Peter Welch, U.S. Congressman, Vermont

Thursday, February 4, 2016

Committee(s):

House Committee on Health Care

2:00 PM

H.866 - An act relating to prescription drug manufacturer cost transparency

Legislation from other states regarding prescription drug cost transparency

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Tuesday, February 16, 2016

Committee(s):

House Committee on Health Care

2:30 PM

H.866 - An act relating to prescription drug manufacturer cost transparency

Wendy Morgan, Assistant Attorney General, Attorney General's Office
Merideth Chaudoir, Assistant Attorney General, Attorney General's Office
Jill Abrams, Assistant Attorney General, Attorney General's Office

Tuesday, February 23, 2016

Committee(s):

House Committee on Health Care

3:15 PM

H.866 - An act relating to prescription drug manufacturer cost transparency

Proposal re manufacturers' fee

Rep. Sarah Copeland-Hanzas

Tuesday, March 8, 2016

Committee(s):

House Committee on Health Care

4:30 PM

H.866 - An act relating to prescription drug manufacturer cost transparency

Or 4:45 PM. Brief discussion.

Rep. Douglas Gage
Rep. Christopher Pearson

Friday, March 11, 2016

Committee(s):

House Committee on Health Care

11:15 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

Committee discussion of draft language re Rx drug cost transparency.

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Susan Barrett, JD, Executive Director, Green Mountain Care Board
Andrew MacLean, Lobbyist, MMR

2:45 PM

H.866 - An act relating to prescription drug manufacturer cost transparency

Mark-up and vote on Committee bill

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Wednesday, March 23, 2016

Committee(s):

House Committee on Health Care

11:00 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

Kathryn Becker Van Haste, Director of Health Policy, Senator Bernie Sanders

Wednesday, March 30, 2016

Committee(s):

House Committee on Health Care

9:00 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

John Murphy, Assistant General Counsel, PhRMA
James Love, Director, Knowledge Ecology International

Thursday, March 31, 2016

Committee(s):

House Committee on Health Care

9:15 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

Susan Barrett, JD, Executive Director, Green Mountain Care Board
Rep. James McCullough, Sponsor of Amendment
Thomas Hall, Founder, Complementary and Alternative Medical Association of Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

11:00 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

Leigh Purvis, Director of Health Services Research, AARP
Ritchard Engelhardt, State Director of Government Affairs, Northeastern and Western Regions, Biotechnology Innovation Organization

Tuesday, April 5, 2016

Committee(s):

House Committee on Health Care

4:15 PM

H.866 - An act relating to prescription drug manufacturer cost transparency

Reshma Ramachandran MD MPP, Research Faculty, Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health
Steven Knievel, Coordinator, Global Access to Medicines Program, Public Citizen

Wednesday, April 6, 2016

Committee(s):

House Committee on Health Care

9:00 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

Dagny Hoff, State Health Insurance Program Coordinator, Central Vermont Council on Aging

Thursday, April 14, 2016

Committee(s):

House Committee on Health Care

5:00 PM

H.866 - An act relating to prescription drug manufacturer cost transparency

Rep. Pearson's proposed strike-all amendment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, April 15, 2016

Committee(s):

House Committee on Health Care

11:00 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

Strike-all amendment from Rep. Pearson.
Other witnesses TBA.

Margaret Laggis, Lobbyist, America's Health Insurance Plans

Thursday, April 21, 2016

Committee(s):

House Committee on Health Care

10:00 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

Amendments, Bancroft and Donahue; vote to amend H.866 with Donahue amendment; then vote out H.866 as amended.

Rep. Robert Bancroft
Rep. Anne B. Donahue

11:35 AM

H.866 - An act relating to prescription drug manufacturer cost transparency

Rep. McCullough amendment re complementary and alternative medicine